----
Current ValuationThe current P/E ratio is -35.60, below the reasonable range, cheaper than 92.73% of the time in the past 3 years, and the industry ranks 69/78, the industry Median -4.96.
-35.6xP/E
HK$15.93Stock price
HK$-0.45Earnings per share
-35.6xP/E
Stock priceHK$15.93Earnings per shareHK$-0.45
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -11.56x
- Typical range
- -26.61x–-5.43x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
0159318477636
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
09926HKAKESO | -74.25x | 75.50% | HK$82.68B |
09688HKZAI LAB | -14.61x | 435.53% | HK$22.73B |
01877HKJUNSHI BIO | -35.60x | 94.97% | HK$16.36B |
07666HKMETIS TECHBIO-P | -32.77x | 96.67% | HK$13.34B |
02627HKAB&B BIO-TECH-B | -46.87x | -- | HK$11.54B |
06855HKASCENTAGE | -6.71x | 18.76% | HK$11.34B |
09606HKDUALITYBIO-B | -6.11x | 85.35% | HK$10.12B |
01952HKEVEREST MED | -158.81x | 326.79% | HK$9.86B |
02595HKGENFLEET-B | -5.98x | 66.07% | HK$9.07B |
02616HKCSTONE PHARMA-B | -18.65x | 1.09% | HK$9.00B |
02493HKMABWELL-B | -6.76x | -- | HK$8.27B |
09887HKLEADS BIOLABS-B | -24.69x | 3.57% | HK$7.59B |
06938HKRIBOLIFE-B | -38.40x | 29.56% | HK$7.50B |
02171HKCARSGEN-B | -65.80x | 52.33% | HK$6.76B |
09966HKALPHAMAB-B | -31.72x | -- | HK$6.43B |
02335HKMICOT PHARMA-B | -12.91x | 37.52% | HK$5.42B |
01672HKASCLETIS-B | -7.56x | 78.53% | HK$5.15B |
00775HKCKLIFE SCIENCES | -78.73x | -- | HK$5.09B |
02256HKABBISKO-B | -9.36x | 797.83% | HK$5.03B |
01779HKLONGBIO-B | -16.97x | -- | HK$4.22B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
